Related Experiment Video
Updated: May 24, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease
Elizabeth A Freiheit1, David B Hogan, Misha Eliasziw
1Department of Community Health Sciences, University of Calgary, Third Floor Teaching Research and Wellness, Calgary.
Insights
Persistent depressive symptoms in older adults with coronary artery disease are linked to significant cognitive decline over 30 months. This decline may be exacerbated by the apolipoprotein E (APOE) ε4 allele.
Area of Science:
- Cardiology
- Geriatrics
- Neuroscience
- Psychiatry
Background:
- Older patients with coronary artery disease (CAD) are susceptible to depressive symptoms and cognitive impairment.
- The relationship between persistent depressive symptoms and cognitive decline in CAD patients is not well understood.
Purpose of the Study:
- To investigate the association between the stability of depressive symptoms and cognitive decline over 30 months in patients undergoing coronary angiography.
- To explore if the apolipoprotein E (APOE) ε4 allele modifies this association.
Main Methods:
- A cohort study involving 350 patients aged 60+ undergoing nonemergent catheterization.
- Depressive symptoms were assessed at baseline and 12 months; cognitive function was measured at baseline, 6, 12, and 30 months.
- Cognitive domains included attention/executive function, learning/memory, verbal fluency, and global cognition (MMSE).
Main Results:
- Persistent depressive symptoms were associated with significantly greater cognitive decline across all measured domains at 30 months.
- This decline was evident from 12 to 30 months, even after adjusting for covariates.
- A more pronounced decline in global cognition was observed in patients with persistent depressive symptoms and the APOE ε4 allele.
Conclusions:
- Persistent depressive symptoms represent a significant risk factor for cognitive decline in patients with coronary artery disease.
- The apolipoprotein E (APOE) ε4 allele may interact with depressive symptoms to accelerate cognitive decline, warranting further investigation.
Context:
Older patients with coronary artery disease often experience depressive symptoms and are vulnerable to developing cognitive impairment. Whether depressive symptoms increase their risk of cognitive decline is unknown.
Objectives:
To examine the association between the stability of depressive symptoms and cognitive decline for 30 months among patients undergoing coronary angiography and to explore whether any observed associations were modified by the presence of the apolipoprotein E (APOE) ε4 allele.
Design:
Cohort study.
Setting:
Urban tertiary care hospital serving southern Alberta.
Participants:
Three hundred fifty patients 60 years or older (73.7% male) undergoing nonemergent catheterization (October 27, 2003, through February 28, 2007) without prior revascularization. We compared a baseline measure of depressive symptoms (Geriatric Depression Scale score ≥5) with a dynamic measure capturing change from baseline to 12 months.
Main Outcome Measures:
Mean change in domain (z scores for attention/executive function, learning/memory, and verbal fluency) and global (raw Mini-Mental State Examination) cognitive scores from baseline to 6, 12, and 30 months and from 12 to 30 months.
Results:
In adjusted models, participants with persistent depressive symptoms (at baseline and ≥1follow-up visit) showed significantly greater declines at 30 months in attention/executive function (mean z score change, -0.22), learning/memory (-0.19), verbal fluency (-0.18), and global cognition (mean Mini-Mental State Examination [MMSE] score change, -0.99) compared with participants with no or baseline-only depressive symptoms. Persistent depressive symptoms were associated with significantly greater declines in all cognitive measures from 12 to 30 months after adjusting for sociodemographic and clinical factors. For global cognition, a significantly greater decline was evident for patients with persistent depressive symptoms and the APOE ε4 allele (mean MMSE score change, -2.93 [95% CI, -4.40 to -1.45]).
Conclusions:
Depressive symptoms persist in some patients with coronary artery disease, placing them at a greater risk for cognitive decline. Whether this decline is additionally modified by the presence of APOE ε4 requires further investigation.
More Related Videos
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Coronary Artery Disease III: Clinical Manifestations
Depression: Overview
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Acute Coronary Syndrome III: Diagnostic Studies

